What cost evidence supports the use of technologies in home and community based caregiving of older adults? Presented by Brooke Harrow, PhD University.

Slides:



Advertisements
Similar presentations
Telehealth: Pursuing, Planning and Prospering Joyce Doughty, BSN, PHN, RN Director Good Samaritan Home Health Care.
Advertisements

MEDICAL HOME 1/2009 Mary Goldman, D.O., President of MAOFP.
Engaging Patients and Other Stakeholders in Clinical Research
Should We Ration Health Care for Older People?
PROFESSIONAL NURSING PRACTICE
November 26, Fall Forum Alberta’s Pharmaceutical Strategy and Programs Policy Recommendations.
1 Addressing Patients’ Social Needs An Emerging Business Case for Provider Investment September 30, 2014 Deborah Bachrach Manatt, Phelps & Phillips, LLP.
Determining Your Program’s Health and Financial Impact Using EPA’s Value Proposition Brenda Doroski, Director Center for Asthma and Schools U.S. Environmental.
1 Wisconsin Partnership Program Steven J. Landkamer Program Manager Wisconsin Dept. of Health & Family Services July 14, 2004.
Islamic University of Gaza Faculty of Nursing
Centre for Health Services Research University of Newcastle upon Tyne.
Budget and Finance Concepts for the CNL Susan J. Penner, RN, MN, MPA, DrPH, CNL.
Documentation for Acute Care
Productivity Prepared by Dr. Manal Moussa. Productivity Prepared by Dr. Manal Moussa.
Budget Impact Analysis and Return on Investment Usa Chaikledkaew, Ph.D.
Chris Gaur, Co-Founder Vital Care Services TeleHealth Research : Assistive Remote Patient Monitoring – Effective e-Health Intervention Pace University.
The Effects of De-listing Publicly Funded Health Care Services Mark Stabile Department of Economics and Center for Economics and Public Affairs University.
Generating evidence for change: Implementing the post-ICIUM research agenda Dennis Ross-Degnan, ScD Harvard Medical School and Harvard Pilgrim Health Care.
Economic Evaluations, Briefly… CHSC 433 Module 6/Chapter 13 UIC School of Public Health L. Michele Issel, PhD, R N.
Evaluating Services & Expenditure in Social Sectors Approaches supported by The Atlantic Philanthropies Gail Birkbeck Feb 1, 2013.
Cost-Effectiveness Problem l You have a $1.5 billion budget to spend on any combination of these programs:
April 29 - May 1, 2015 Community and Home-Based Solutions for All Ages- Community Health Navigator Program.
Economic evaluation of health programmes Department of Epidemiology, Biostatistics and Occupational Health Class no. 1: Introduction Sept 3, 2008.
COMPARATIVE EFFECTIVENESS RESEARCH AND THE CALIFORNIA MEDI-CAL PROGRAM Len Finocchio, Dr.P.H Associate Director California Department of Health Care Services.
PHAR 310: Pharmacoeconomics
EVIDENCE BASED MEDICINE Health economics Ross Lawrenson.
Knowing what you get for what you pay An introduction to cost effectiveness FETP India.
Cost Analysis of TeleHomecare  Kathryn H. Dansky, R.N., PhD  Liisa Palmer, PhD candidate  Dennis Shea, PhD  Kathy Bowles, R.N., PhD.
Adopting New Technology Into Society: Going From an Idea to an Institution Michael J. Ackerman, Ph.D. Assistant Director High Performance Computing and.
AWPHD Legislative Summary House Bill 1196: Increasing the dollar limit for small works roster projects House Bill 1847: Increases bid limits for public.
Community Paramedic. Benchmark 101 We need a description of the epidemiology of the medical conditions targeted by the community paramedicine program.
Challenges of Directing CCU in Egypt Hossam Kandil, MD Professor of Cardiology Cairo University Hossam Kandil, MD Professor of Cardiology Cairo University.
Health Economics Unit Definition of Economics  Demand − relationship between quantities and prices that addresses how much bought at each price.
Defining Roles and Responsibilities for the New College Health Nurse through Standardized Nursing Competencies Doreen Perez MS RN BC Carol Kozel BSN RN.
Health Resources & Services Administration Office of Rural Health Policy Office for the Advancement of Telehealth Presented by Lawrence Bryant
Evidence-Based Public Health Nancy Allee, MLS, MPH University of Michigan November 6, 2004.
Cost-Effectiveness of Palliative Team Care For Patients Nearing End-Of-Life Society for Medical Decision Making 36 st Annual Meeting – Miami, Florida October.
Baltimore Buprenorphine Initiative Advancing Recovery Project Baltimore City, Maryland January 14, 2010.
Mohammad Aljawadi PharmD, PhD Clinical Pharmacy Department King Saud University PHCL 431 Sep, 2015.
The new London Brokerage Network. What is Brokerage? Bit of a postcode lottery Ideal v current reality.
Managed Care. In the broadest terms, Kongstvedt (1997) describes managed care as a system of healthcare delivery that tries to manage the cost of healthcare,
PHARMACOECONOMICS Dr. Mohammad Aljawadi, PharmD PhD Department of Clinical Pharmacy King Saud University Aug, 2015 PHCL 431.
The Third Annual Medical Device Regulatory, Reimbursement and Compliance Congress Reimbursement: A Look Inside the Black Box Eric L. Book, MD March 27,
Linda Felver, Ph.D., R.N.. Three of them focus on individual older adults. The next three focus on older adults and caregiver issues. The last three focus.
Chapter 18 by Sheldon Prial and Schuyler F. Hoss Overview of Home Telehealth.
Preliminary Report Joint Legislative Audit and Review Committee Cynthia L. Forland September 14, 2005 At-Risk Youth Study.
Building “Win/Win/Win” Relationships through AT Reuse: A Closer Look at Medicaid Collaborations Presenters: Sara Sack, Assistive Technology for Kansans;
Technology and Innovative Home and Community Based Care
CRITICAL THINKING AND THE NURSING PROCESS Entry Into Professional Nursing NRS 101.
Standards 2.2 Evaluate the use of tele-health care in the delivery of health care in a clinical and home setting 2.2 Evaluate the use of tele-health.
Cost-Effectiveness and Outcomes Research Setting value to what we do.
Health Policy Analysis: Chapters 10, 11 and 14 Nutchanart Bunthumporn Beth Faiman.
EVALUATION RESEARCH To know if Social programs, training programs, medical treatments, or other interventions work, we have to evaluate the outcomes systematically.
Understanding Policy Regulations and Reimbursement Practices Impacting Telehealth Programs Rena Brewer, RN, MA CEO, Global Partnership for Telehealth Lloyd.
Community Connections Heather Altman, MPH Project Director, Community Connections Carol Woods Retirement Community /
A Cost-Effectiveness Analysis of Maternal Genotyping to Guide Treatment in Postnatal Patients.
` ASystematic review of the effectiveness of nurse coordinated transitioning of care on readmission rates for patients with heart failure Jason T. Slyer.
Comparative Effectiveness Research (CER) and Patient- Centered Outcomes Research (PCOR) Presentation Developed for the Academy of Managed Care Pharmacy.
Best Practices for Asthma Management: NAEPP/NHLBI Guidelines 1. Lung function measurement 2. Comprehensive pharmacologic therapy 3. Control of environmental.
Palliative Care with Older Adults Section 3: Policy Issues Related To Aging And Palliative Care Gunnar Almgren, PhD University of Washington, School of.
Implications and Limitations The Asthma H.E.L.P. program demonstrates that an asthma management program can be integrated into the casework process of.
Use of Personal Assistance Services by Public Insurance Recipients with Tetraplegic Injuries: Policy Recommendations Advanced by Spinal Cord Injury Consumers.
Welcome to Learning 2: Care Management October 2011 Connie Sixta, RN, PhD, MBA.
Maryland’s ADRC Evidence Based Transitions Grant Project: the Guided Care Model Ilene Rosenthal Deputy Secretary Maryland Department of Aging.
Telehealth Implementation: Strategy for Measuring Impact on Quality, Access and Cost Kathleen Webster MD, FAAP Background Our Initial Goals Setting Program.
RTI International is a trade name of Research Triangle Institute The Costs of SBI: Findings from the literature Presented by Jeremy Bray, Gary.
Tamara Broadnax, MSN, RN, NEA-BC VCU Health Telemedicine Director
Chapter 10: Cost-Effectiveness and Cost Analysis Designs
Paying for Serious Illness Care Under a Global Budget: Opportunities and Challenges Anna Gosline, Senior Director of Health Policy and Strategic Initiatives,
Making Healthcare Affordable
Presentation transcript:

What cost evidence supports the use of technologies in home and community based caregiving of older adults? Presented by Brooke Harrow, PhD University of Massachusetts, Boston Co-authors: Linda W. Samia, RN, MSN, CNAA, Russell E. Morgan, Jr., Dr.P.H. Supported by the National Institute of Nursing Research (Grant #NR04350) and the SPRY Foundation

Overview of this presentation The progression of home based technology How are new technologies being assessed in terms of cost? What do we know about the cost methodology being used? What is the current cost evidence? What direction do we go from here?

Introduction Technology has driven health care costs in the institutional setting Until recently there has been little concern about the cost-effectiveness of these technologies. More recently focus turned to cost-effectiveness of new technologies as payers make decisions about reimbursement policies Ironically, this increased focus includes caregiving technology that keeps older adults out of institutional settings.

Progression of home technology Low-cost: personal emergency response systems Relatively uncomplicated therapeutic measures such as home oxygen dispensers High-cost: high tech therapeutic interventions

Our interest today: Technology for caregiving support New devices or services providing caregiving support rather than the medicalization of the home. Tele-health or Telemedicine: The delivery of health care services over distances using electronic information and communication technologies

Goals of computer-based technology to assist community based caregiving Increase home health care access to underserved areas Ease caregiver burden Improve patient involvement in management of her condition Prevent exacerbations that could result in hospitalizations

Why do we care about cost? To succeed in the development and adoption of new technology, there must be added value that can be demonstrated. In health care, this value needs to be convincing to third party payers.

How are new technologies being assessed in terms of costs? Cost Minimization Analysis: Least costly alternative that produces equivalent outcomes. Cost Effectiveness Analysis (CEA): Costs in monetary units, outcomes in non-monetary units Cost Utility analysis: Form of CEA, with outcomes in terms of utility or quality adjusted life years Cost Benefit analysis: costs and outcomes both in monetary units The Lewin Group, Assessment of Approaches to Evaluating Telemedicine, Final report to the Office of the Assistant Secretary for Planning and Evaluation, Department of Health and Human Services, Contract Number HHS , December 2000

Example of a cost-benefit analysis for technologies that maintain older adults in the community Savings related to nursing home cost easily calculated. Any delay in institutionalization can be compared with cost of technology Technology that allows caregivers to spend less time on informal care also represents cost savings These savings are compared to the cost of the technology

Cost Methodology Identify both direct cost and indirect costs of technology. May include: –Clinician and other labor cost –Equipment –Training and maintenance –Upgrades –Ongoing telecommunications –Caregiver time

Cost Perspective Refers to the standpoint from which costs and benefits (or outcomes) are realized Can be either from the clinician, patient, agency, payer or society. Economic perspective must be explicit The Lewin Group, Assessment of Approaches to Evaluating Telemedicine, Final report to the Office of the Assistant Secretary for Planning and Evaluation, Department of Health and Human Services, Contract Number HHS , December 2000

Other issues related to cost methodology Time Horizon: capturing utilization and cost data beyond the project start-up period Fixed costs of technology are high and it might be appropriate to describe both average costs and marginal costs of the technology Future cost and outcomes must be discounted relative to their present value Sensitivity analyses should be performed to determine how variation in estimates effect the analyses. The Lewin Group, Assessment of Approaches to Evaluating Telemedicine, Final report to the Office of the Assistant Secretary for Planning and Evaluation, Department of Health and Human Services, Contract Number HHS , December 2000

What is the current cost evidence? With respect to home health care: –Cost of a traditional in-home registered nurse visit is $112 compared to about half that for the cost of a tele- health visit –A nurse can visit patients every minutes versus every 75 minutes With newly capitated episodic reimbursement, home health agencies are very interested in exploring alternative ways to deliver nursing services to the homebound

What do we know from systematic reviews of cost-effectiveness studies? Wootton’s review (2001) found little hard evidence of cost- effectiveness for home “telenursing”and suggests it may be difficult to have cost-effective use of technology in the home if it requires expensive equipment. Pamela Whitten and colleagues (2002) review of cost- effectiveness studies for telemedicine interventions found “no persuasive evidence”of cost-effectiveness Wootton R. Recent advances: Telemedicine. BMJ 2001;323:557–60 Whitten, P., Mair, F. S., Haycox, A., May, C. R., (2002). Systematic review of cost effectiveness studies of telemedicine interventions. British Medical Journal, 324,

Future cost analyses Should have the scientific rigor and follow the most up-to-date cost-effectiveness analysis techniques so that informed decisions can be made about adoption of new technology. Cost-effectiveness can mean that the additional benefit is worth the cost

Where do we go from here? Critics of the emphasis on cost-effectiveness argue that the demand for scientific rigor in the study of new technologies will impede progress in medical practice. Are we holding technology for community- based caregiving to a higher standard that has been held to technology used in institutional settings?

What if it really does cost more to provide this high tech support? Expensive technology to support medical needs is already being used in the home setting as reimbursement policies have moved patients out of the institutional setting and into the home. However, the basic needs of many patients for non-medical community support often get unmet. We need to decide as a society if there is a price we are willing to pay for increased quality of life for community dwelling older adults.